Status:
RECRUITING
The Benefits of Hippotherapy for Patients With Parkinson's Disease of 75 Years
Lead Sponsor:
Central Hospital Saint Quentin
Conditions:
Parkinson Disease
Eligibility:
All Genders
75+ years
Phase:
NA
Brief Summary
There is no cure for Parkinson's disease, resulting in an interest for research in this domain. Non pharmacological measures remain essential, specifically physical activity. Hippotherapy is a nonconv...
Detailed Description
Parkinson's disease is a degenerative disorder with a prevalence of 2.50 patients per 1,000 people in 2015. Prevalence and incidence increase progressively with age up to the age of 80; more than half...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age ≥ 75 years with PD according to Movement Disorders Society criteria (2015).
- Clinical diagnosis of Alzheimer's disease
- Has been on stable antiparkinsonian treatment for less than 3 months.
- Ability to understand the principle of the study as well as its risks.
- Written consent to participate in the trial.
- Have social insurance
- Agree to comply with all safety procedures during the study and its duration.
- Ability to understand and freely give consent
- Patient affiliated to social security or entitled beneficiary
- Autonomy preserved
- Exclusion criteria :
- age \<75 years
- refusal to sign consent
- MOCA \<23
- Presence of major behavioural problems that do not allow MRI to be performed under optimal conditions
- Subjects unable to receive informed information, unable to participate in the study as a whole
- Subjects with a diagnosis of atypical parkinsonian syndrome (Lewy body disease, progressive supranuclear palsy, multisystem atrophy, cortico-basal degeneration, etc.).
- A classic contraindication to an MRI examination: claustrophobia, presence of incompatible foreign material,
- Subjects who have practised horse riding at a high level, animal phobias, wish to stop studying, etc.
- No affiliation to a social security scheme
- Antiparkinsonian treatment has not been stable for at least 3 months.
- People under protective supervision (guardianship, curatorship)
- People under family guardianship are also excluded, as are people for whom a mandate for future protection has been activated.
Exclusion
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06500182
Start Date
July 1 2023
End Date
July 1 2024
Last Update
July 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Saint-Quentin;
Saint-Quentin, Aisne, France, 02100